These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6707910)

  • 1. Relationship between N-acetylator phenotype and susceptibility toward hydrazine-induced lethal central nervous system toxicity in the rabbit.
    Hein DW; Weber WW
    J Pharmacol Exp Ther; 1984 Mar; 228(3):588-92. PubMed ID: 6707910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylation pharmacogenetics: experimental models for human toxicity.
    Weber WW
    Fed Proc; 1984 May; 43(8):2332-7. PubMed ID: 6714442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically determined variability in acetylation and oxidation. Therapeutic implications.
    Clark DW
    Drugs; 1985 Apr; 29(4):342-75. PubMed ID: 2859977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylation.
    Weber WW
    Birth Defects Orig Artic Ser; 1990; 26(1):43-65. PubMed ID: 2224079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acetylation phenotype of isoniazid in Morocco. Preliminary study of 100 cases].
    Bouayad Z; Chevalier B; Maurin R; Bartal M
    Rev Fr Mal Respir; 1982; 10(6):401-7. PubMed ID: 7163595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylator phenotype and short-course chemotherapy for tuberculosis in Papua New Guinea.
    Currie B; Krause V; Mondia P; Hudson B
    P N G Med J; 1989 Dec; 32(4):259-62. PubMed ID: 2560598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of genetically homozygous rapid and slow acetylators of drugs and environmental carcinogens among established inbred rabbit strains.
    Hein DW; Smolen TN; Fox RR; Weber WW
    J Pharmacol Exp Ther; 1982 Oct; 223(1):40-4. PubMed ID: 7120125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the acetylation polymorphism in determining susceptibility of cultured rabbit hepatocytes to DNA damage by aromatic amines.
    McQueen CA; Maslansky CJ; Williams GM
    Cancer Res; 1983 Jul; 43(7):3120-3. PubMed ID: 6850620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetylation of drugs. Pharmacogenetic studies in rabbits selected for their acetylator characteristics.
    Weber WW; Miceli JN; Hearse DJ; Drummond GS
    Drug Metab Dispos; 1976; 4(1):94-101. PubMed ID: 3408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of the toxic hydrazino metabolites formed from isoniazid in humans.
    Lauterburg BH; Smith CV; Todd EL; Mitchell JR
    J Pharmacol Exp Ther; 1985 Dec; 235(3):566-70. PubMed ID: 4078724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphic N-acetylation of phenelzine and monoacetylhydrazine by highly purified rabbit liver isoniazid N-acetyltransferase.
    Hein DW; Weber WW
    Drug Metab Dispos; 1982; 10(3):225-9. PubMed ID: 6125354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Isoniazid acetylation in a group of Tunisian patients. Report of 620 patients].
    Mehiri BR; Zouaoui A; Chérif J; Ourari B; Daghfous R; Oueslati MH; Louzir B; Daghfous J; Chelbi B; Béji M
    Tunis Med; 2005 Jul; 83(7):385-9. PubMed ID: 16220693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotoxicity of isoniazid and its metabolites in cultures of mouse dorsal root ganglion neurons and hybrid neuronal cell line.
    Sanfeliu C; Wright JM; Kim SU
    Neurotoxicology; 1999 Dec; 20(6):935-44. PubMed ID: 10693974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoacetylhydrazine as a metabolite of isoniazid in man.
    Timbrell JA; Wright JM; Baillie TA
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):602-8. PubMed ID: 913027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylator phenotyping with sulphadimidine in patients receiving isoniazid.
    Ylitalo P; Auterinen L; Marttinen A; Koivula T
    Int J Clin Pharmacol Res; 1984; 4(2):141-4. PubMed ID: 6469440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylation of acetylhydrazine, the toxic metabolite of isoniazid, in humans. Inhibition by concomitant administration of isoniazid.
    Peretti E; Karlaganis G; Lauterburg BH
    J Pharmacol Exp Ther; 1987 Nov; 243(2):686-9. PubMed ID: 3681700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of host genetic susceptibility to genotoxic chemicals in hepatocyte cultures.
    McQueen CA; Williams GM
    IARC Sci Publ; 1982; (39):413-20. PubMed ID: 7152618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seizures induced by theophylline and isoniazid in mice.
    Bonner AB; Peterson SL; Weir MR
    Vet Hum Toxicol; 1999 Jun; 41(3):175-7. PubMed ID: 10349711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification of children as slow or rapid acetylators based on concentrations of isoniazid in saliva following oral administration of body-weight and surface-area-related dosages of the drug.
    Sarma GR; Kailasam S; Datta M; Loganathan GK; Rahman F; Narayana AS
    Indian Pediatr; 1990 Feb; 27(2):134-42. PubMed ID: 2361757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability factors of isoniazid in fast and slow acetylators, healthy volunteers.
    Augustynowicz-Kopeć E; Zwolska Z
    Acta Pol Pharm; 2002; 59(6):452-7. PubMed ID: 12669770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.